edoxaban has been researched along with Body-Weight* in 1 studies
1 trial(s) available for edoxaban and Body-Weight
| Article | Year |
|---|---|
Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups.
To compare the efficacy and safety of edoxaban vs warfarin in high-risk subgroups.. While underuse of anticoagulation in high-risk patients with AF remains common, substitution of effective and safer alternatives to warfarin, such as edoxaban, represents an opportunity to improve clinical outcomes. Topics: Aged; Anticoagulants; Atrial Fibrillation; Body Weight; Factor Xa Inhibitors; Humans; Pyridines; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2022 |